All In MedTech

Device Trial Radar · NCT05756309

Validation of ECG Waveform and Arrhythmia Diagnosis Concordance for Pediatric Patients Using ECG Monitoring Patch

Validation of Electrocardiogram Waveform, Heart Rate Accuracy and Arrhythmia Diagnosis Concordance for Pediatric Patients Using Single-channel ECG Monitoring Patch and Holter Monitoring

Last checked: Nov 20, 2026Latest source record: Aug 9, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

105

Planned (sponsor's estimate)

Start

Jan 16, 2023

Primary completion

Dec 30, 2024

Study completion Dec 30, 2024

Sponsor

Lead sponsor
Mezoo Co., Ltd.Academic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Mar 6, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
No
Who can join
All sexes, from 29 days, up to 19 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will verify the 1-channel patch-type ECG's arrhythmia diagnostic concordance rate and electrocardiogram measurement performance in pediatric patients by collecting ECG signals from patch-type ECG and Holter device simultaneously for data analysis.

Conditions

  • Arrhythmias, Cardiac

Interventions

  • Electrocardiogram measurements by holter device and patch-type electrocardiographic at the same timeDevice

    The patient is measured electrocardiogram simultaneously through a holter device and patch-type electrocardiograph

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of arrhythmia diagnosis between patch-type electrocardiograph and commercial Holter device measurement data by arrhythmia categoriesTime frame: Within 3 months after electrocardiogram procedure
  2. Rate of ECG signal concordance between patch-type electrocardiograph and holter deviceTime frame: Within 3 months after electrocardiogram procedure

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Samsung Medical Center

    Seoul, South Korea · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.